| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1253674
[patent_doc_number] => 06670397
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => 'Methods for transdifferentiation of body tissues'
[patent_app_type] => B1
[patent_app_number] => 09/856881
[patent_app_country] => US
[patent_app_date] => 2001-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 14557
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670397.pdf
[firstpage_image] =>[orig_patent_app_number] => 09856881
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/856881 | Methods for transdifferentiation of body tissues | May 23, 2001 | Issued |
| 60/367353 | Compositions and methods for enhancing the bioavailability of pharmaceutical agents | Apr 30, 2001 | Pending |
Array
(
[id] => 1399213
[patent_doc_number] => 06531489
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-03-11
[patent_title] => 'Single isomer methylphenidate and resolution process'
[patent_app_type] => B2
[patent_app_number] => 09/836731
[patent_app_country] => US
[patent_app_date] => 2001-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1516
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/531/06531489.pdf
[firstpage_image] =>[orig_patent_app_number] => 09836731
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/836731 | Single isomer methylphenidate and resolution process | Apr 16, 2001 | Issued |
Array
(
[id] => 1369938
[patent_doc_number] => 06566401
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-05-20
[patent_title] => 'N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity'
[patent_app_type] => B2
[patent_app_number] => 09/833228
[patent_app_country] => US
[patent_app_date] => 2001-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7478
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/566/06566401.pdf
[firstpage_image] =>[orig_patent_app_number] => 09833228
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/833228 | N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity | Apr 10, 2001 | Issued |
Array
(
[id] => 6886738
[patent_doc_number] => 20010020007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-06
[patent_title] => 'Vitamin preparations for reducing oxygen consumption during physical efforts'
[patent_app_type] => new
[patent_app_number] => 09/824801
[patent_app_country] => US
[patent_app_date] => 2001-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11958
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20010020007.pdf
[firstpage_image] =>[orig_patent_app_number] => 09824801
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/824801 | Vitamin preparations for reducing oxygen consumption during physical efforts | Apr 3, 2001 | Abandoned |
Array
(
[id] => 6961852
[patent_doc_number] => 20010012842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-09
[patent_title] => 'Methods and compositions for treating infection using optically pure (S)-lomefloxacin'
[patent_app_type] => new
[patent_app_number] => 09/794006
[patent_app_country] => US
[patent_app_date] => 2001-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5843
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20010012842.pdf
[firstpage_image] =>[orig_patent_app_number] => 09794006
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/794006 | Methods and compositions for treating infection using optically pure (S)-lomefloxacin | Feb 27, 2001 | Issued |
Array
(
[id] => 6174376
[patent_doc_number] => 20020155082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Siloxane dyes, compositions containing them and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/777933
[patent_app_country] => US
[patent_app_date] => 2001-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3890
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20020155082.pdf
[firstpage_image] =>[orig_patent_app_number] => 09777933
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/777933 | Siloxane dyes, compositions containing them and uses thereof | Feb 6, 2001 | Issued |
Array
(
[id] => 5802276
[patent_doc_number] => 20020010194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches'
[patent_app_type] => new
[patent_app_number] => 09/775724
[patent_app_country] => US
[patent_app_date] => 2001-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 30297
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20020010194.pdf
[firstpage_image] =>[orig_patent_app_number] => 09775724
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/775724 | Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches | Jan 31, 2001 | Abandoned |
Array
(
[id] => 7028712
[patent_doc_number] => 20010014676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-16
[patent_title] => 'Immunosuppressive compositions'
[patent_app_type] => new
[patent_app_number] => 09/772389
[patent_app_country] => US
[patent_app_date] => 2001-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3584
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20010014676.pdf
[firstpage_image] =>[orig_patent_app_number] => 09772389
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/772389 | Immunosuppressive compositions | Jan 28, 2001 | Abandoned |
Array
(
[id] => 5889361
[patent_doc_number] => 20020013373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'Methods and compositions for treatment of asthma'
[patent_app_type] => new
[patent_app_number] => 09/770631
[patent_app_country] => US
[patent_app_date] => 2001-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 5783
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20020013373.pdf
[firstpage_image] =>[orig_patent_app_number] => 09770631
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/770631 | Methods and compositions for treatment of asthma | Jan 28, 2001 | Abandoned |
Array
(
[id] => 6033671
[patent_doc_number] => 20020019423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Anti-viral triaza compounds'
[patent_app_type] => new
[patent_app_number] => 09/769021
[patent_app_country] => US
[patent_app_date] => 2001-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12301
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019423.pdf
[firstpage_image] =>[orig_patent_app_number] => 09769021
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/769021 | Anti-viral triaza compounds | Jan 24, 2001 | Abandoned |
Array
(
[id] => 7041243
[patent_doc_number] => 20010005727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-06-28
[patent_title] => 'Composition to alleviate pain and topical method of applying same'
[patent_app_type] => new-utility
[patent_app_number] => 09/766280
[patent_app_country] => US
[patent_app_date] => 2001-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3036
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20010005727.pdf
[firstpage_image] =>[orig_patent_app_number] => 09766280
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/766280 | Composition to alleviate pain and topical method of applying same | Jan 18, 2001 | Issued |
Array
(
[id] => 5829320
[patent_doc_number] => 20020068757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-06
[patent_title] => 'Biflavanoids and derivatives thereof as antiviral agents'
[patent_app_type] => new
[patent_app_number] => 09/761909
[patent_app_country] => US
[patent_app_date] => 2001-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24130
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20020068757.pdf
[firstpage_image] =>[orig_patent_app_number] => 09761909
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/761909 | Biflavanoids and derivatives thereof as antiviral agents | Jan 16, 2001 | Abandoned |
| 09/647270 | Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors | Dec 20, 2000 | Abandoned |
Array
(
[id] => 7105504
[patent_doc_number] => 20010004644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-06-21
[patent_title] => 'Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation'
[patent_app_type] => new-utility
[patent_app_number] => 09/737302
[patent_app_country] => US
[patent_app_date] => 2000-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 37092
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20010004644.pdf
[firstpage_image] =>[orig_patent_app_number] => 09737302
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/737302 | Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation | Dec 14, 2000 | Abandoned |
Array
(
[id] => 6886774
[patent_doc_number] => 20010020043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-06
[patent_title] => 'Method of inhibiting formation of infectious microorganisms'
[patent_app_type] => new
[patent_app_number] => 09/734444
[patent_app_country] => US
[patent_app_date] => 2000-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3834
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20010020043.pdf
[firstpage_image] =>[orig_patent_app_number] => 09734444
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/734444 | Method of inhibiting formation of infectious microorganisms | Dec 10, 2000 | Issued |
Array
(
[id] => 6142185
[patent_doc_number] => 20020002139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-03
[patent_title] => 'Methods for treating pathologies'
[patent_app_type] => new
[patent_app_number] => 09/730003
[patent_app_country] => US
[patent_app_date] => 2000-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3492
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20020002139.pdf
[firstpage_image] =>[orig_patent_app_number] => 09730003
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/730003 | Methods for treating pathologies | Dec 3, 2000 | Abandoned |
Array
(
[id] => 1399654
[patent_doc_number] => 06531510
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-11
[patent_title] => 'N,N-bis(2-hydroxybenzyl)ethylenediamine-N,N-diacetic acid in iron chelating therapy'
[patent_app_type] => B1
[patent_app_number] => 09/724823
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6273
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/531/06531510.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724823
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724823 | N,N-bis(2-hydroxybenzyl)ethylenediamine-N,N-diacetic acid in iron chelating therapy | Nov 27, 2000 | Issued |
| 09/721088 | Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine | Nov 21, 2000 | Abandoned |
| 09/709383 | Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors | Nov 12, 2000 | Abandoned |